共 50 条
- [32] Dupilumab as a treatment for cutaneous immune-related adverse events induced by immune checkpoint inhibitors: A case series and review of the literature SAGE OPEN MEDICAL CASE REPORTS, 2023, 11
- [36] Dupilumab for Chronic Prurigo in Different Backgrounds: A Case Series CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 1863 - 1867